French Pharma Stock News

If you have been keeping an eye on Renault stock and mulling over your next move, you are not alone. With the price dipping by 3.2% over the past week and sliding 1.6% in the last month, it is natural to wonder whether now is a risk or an opportunity. The year-to-date picture feels even more dramatic, showing a drop of 27.3%. However, if you look at the longer term, there is a transformation: over three and five years, Renault has delivered impressive returns of 17.7% and 63.5% respectively...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Pernod Ricard (ENXTPA:RI) caught investors’ attention after its Annual General Meeting, where shareholders approved all resolutions, including confirmation of the annual dividend and several key board appointments. This combination sets a clear tone for the months ahead. See our latest analysis for Pernod Ricard. Even with recent board appointments and steady dividend policy providing a tone of stability, Pernod Ricard’s share price momentum has struggled to regain its previous highs. After a...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

As the European stock markets continue to show resilience with the pan-European STOXX Europe 600 Index rising by 1.68% and major indices such as Germany's DAX and the UK's FTSE 100 also posting gains, investors are keenly assessing opportunities that may be trading below their estimated value. In this environment of improved business activity and consumer confidence, identifying stocks that are undervalued can provide potential avenues for growth, especially when considering companies with...

Key Insights Given the large stake in the stock by institutions, Valeo's stock price might be vulnerable to their...

Toosla Société Anonyme's ( EPA:ALTOO ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a buy right now...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Key Insights ABIONYX Pharma's significant retail investors ownership suggests that the key decisions are influenced by...

The board of Thales S.A. ( EPA:HO ) has announced that it will pay a dividend of €0.95 per share on the 4th of...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider...

The MGI Digital Technology Société Anonyme ( EPA:ALMDG ) share price has fared very poorly over the last month, falling...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...

In recent commentary, Safran's CEO reported that fourth quarter LEAP engine deliveries are expected to closely match third quarter levels, while CFM is continuing talks for a potential Boeing 737 engine deal with a Turkish airline. This update highlights both the stability of Safran’s core engine operations and the ongoing pursuit of new business opportunities within the commercial aerospace sector. We'll explore how the steady outlook for LEAP engine deliveries shapes Safran's current...

Mersen recently reported Q3 results that missed market expectations, citing ongoing weakness in its solar power segment and reducing its full-year organic sales growth, profit margin, and capital expenditure guidance due to a lack of recovery in this area. An important takeaway is that management expressed limited visibility on a turnaround in the solar segment, prompting analysts to anticipate downward revisions to consensus estimates for the company. We'll explore how weak activity and...

Vinci (ENXTPA:DG) just released third quarter results showing its revenue climbed 5% to €19.4 billion. Traffic at Vinci Airports also increased. The company reaffirmed its 2025 outlook and addressed France’s higher corporate tax charges. See our latest analysis for Vinci. Vinci’s solid quarterly revenue gains and growth in airport traffic have helped the company maintain strong operational momentum this year, even with higher French corporate taxes on the horizon. The shares now trade at...

Pernod Ricard recently reported first quarter 2026 sales of €2,384 million and updated its medium-term guidance, projecting average annual organic net sales growth of 3% to 6% through fiscal years 2027-2029, with ongoing margin expansion. The reaffirmed guidance for fiscal year 2026, combined with clear medium-term targets, gives investors greater visibility into expected growth drivers and profitability trends. We'll explore how management’s projection of organic net sales growth and margin...

Interest around STMicroelectronics (ENXTPA:STMPA) jumped this week as the company released its third-quarter earnings. While STMicroelectronics beat analyst estimates for Q3, shares dropped sharply after it lowered its sales outlook for the full year. See our latest analysis for STMicroelectronics. STMicroelectronics’ share price has taken a real hit, down over 13% last week, despite beating Q3 estimates and announcing new products and board changes. That sharp drop reflects fading momentum...

Unibail-Rodamco-Westfield (ENXTPA:URW) has seen its shares fluctuate over the past week, reflecting ongoing investor interest in the commercial real estate sector. With a steady return in the past month, there is an upbeat mood among shareholders. See our latest analysis for Unibail-Rodamco-Westfield. Unibail-Rodamco-Westfield's share price has climbed 23.26% year-to-date, while the past year’s total shareholder return of 23.11% and a notable 109.58% over three years highlight upward momentum...

Earlier this month, Dassault Systèmes cut its annual revenue growth outlook to 4%-6% for 2025 and reported third-quarter results that came in below expectations, while reaffirming its 7%-10% diluted EPS growth target. An expanded partnership between Medidata, a Dassault Systèmes company, and Sanofi to advance clinical research highlights the potential for innovation within its Life Sciences segment, despite current challenges. We will examine how Dassault Systèmes' lowered full-year revenue...

Mersen (ENXTPA:MRN) caught investor attention after its shares took a steep dive, following the release of Q3 results that fell short of expectations. This was driven largely by sluggish performance in its solar power segment. See our latest analysis for Mersen. After gaining impressive ground for much of 2024, Mersen's share price has now swung sharply as recent weak solar segment results rattled the market. The stock dropped 18.3% in a single day but still holds a 12.4% year-to-date price...

Bureau Veritas (ENXTPA:BVI) shares have seen a steady climb over the past month, gaining more than 10%. Investors are taking note of the company’s recent momentum as they look for clues about whether this move could continue. See our latest analysis for Bureau Veritas. While Bureau Veritas has enjoyed a strong 1-month share price return of nearly 11%, this builds on a longer-term track record reflected in a 1-year total shareholder return of 1.3% and an impressive 73.5% gain over five years...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider...